Scientists using vaginal fluids to develop vaccine
HEALTH & SCIENCE
Scientists at UoN are using women due to their high predisposition to sexual infections compared to men. [Courtesy]
Scientists at the University of Nairobi are studying the vaginal secretions of volunteers to develop vaccines that stop the HIV virus during intercourse for women only.
The scientists attached to the Kenya Aids Vaccine Initiative (KAVI) are using women due to their high predisposition to sexual infections compared to men. Their genitalia have a wider surface of interaction with the virus doubling likelihood of infection at 6.6 per cent compared to 3.1 per cent for men.
UoN Team on Course to Create Women s Only HIV Vaccine
kenyans.co.ke - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kenyans.co.ke Daily Mail and Mail on Sunday newspapers.
Uganda: Is Uganda Ready to Acquire the Covid-19 Vaccine?
allafrica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allafrica.com Daily Mail and Mail on Sunday newspapers.
Is Uganda ready to acquire the Covid-19 vaccine?
Monday December 21 2020
A nurse holds a phial of the Pfizer-BioNTech Covid-19 vaccine at Guy’s Hospital, in central London on December 8, 2020. PHOTO | AFP
Advertisement
The severity of the attacks is often assessed ‘country by country’ or ‘continent by continent’.
To date, the most dangerous and severe viral disease outbreak has been Covid-19, which has affected the economies of almost all countries. So far, about 68,703,109 cases have been registered worldwide. Of these, 1,566,088 have died while recoveries stand at 47,642,036.
No known cure has been developed. However, scientists have been tasked with developing an effective and safe vaccine as opposed to providing a random treatment for corona patients.